跳至主要内容
临床试验/NCT02862756
NCT02862756已完成不适用

Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms

CHU de Reims2 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2016年11月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
CHU de Reims
入组人数
250
试验地点
2
主要终点
Thromboembolic complication

研究概览

简要总结

Endovascular treatment of ruptured and unruptured intracranial aneurysms presents complications, mainly the thrombo-embolic complication. No specific studies have been conducted to study factors associated with the occurrence of thromboembolic complications (symptomatic or not) post endovascular treatment of intracranial aneurysms.

详细描述

In this multicenter, prospective study, patients with treatment of unruptured intracranial aneurysms will be recruited. The thromboembolic complications will be research using diffusion-weighted MRI.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient having a programmed endovascular treatment for unruptured intracranial aneurysm
  • patient older than 18 years
  • patient consenting to participate to the study
  • patient enrolled in the national healthcare insurance program

排除标准

  • patients with contraindications for MRI
  • patients whose clinical condition does not allow sufficient cooperation to the realization of MRI
  • patients with arteriovenous malformation intracranial

结局指标

主要结局

Thromboembolic complication

时间窗: 72 hours after endovascular treatment

Thromboembolic complication diagnosed using diffusion-weighted MRI

次要结局

未报告次要终点

研究者

发起方
CHU de Reims
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验